Catatonia: A Review

References

• Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160:1233–1241.
   Google Scholar
• Pfuhlmann B, Stober G. The different conceptions of catatonia: historical overview and critical discussion. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl1):I4–I7.
   Google Scholar
• Stober G, Pfuhlmann B, Nurnberg G, Schmidtke A, Reis A, Franzek E, Wienker TF. Towards the genetic basis of periodic catatonia: pedigree sample for genome scan I and II. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I25–I30.
   Google Scholar
• Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003; 160:4–12.
   Google Scholar
• Fujii DE, Ahmed I. Is psychosis a neurobiological syndrome? Can J Psychiatry. 2004;49:713–718.
   Google Scholar
• American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Abrams R, Taylor MA. Catatonia. A prospective clinical study. Arch Gen Psychiatry. 1976;33:579–581.
   Google Scholar
• Ungvari GS, Leung SK, Ng FS, Cheung HK, Leung T. Schizophrenia with prominent catatonic features (–catatonic schizophrenia–): I. Demographic and clinical correlates in the chronic phase. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:27–38.
   Google Scholar
• Fink M, Taylor A. Catatonia: A Clinician–s Guide to Diagnosis and Treatment. New York, Cambridge University Press; 2003.
   Google Scholar
• Bleuler E. Dementia Praecox or the Group of Schizophrenias (1908). Translated by Zinkin J; edited by Robertson GM. New York: International Universities Press; 1950.
   Google Scholar
• Stompe T, Ortwein-Swoboda G, Ritter K, Schanda H, Friedmann A. Are we witnessing the disappearance of catatonic schizophrenia? Compr Psychiatry. 2002;43:167–174.
   Google Scholar
• Oulis P, Lykouras L. Prevalence and diagnostic correlates of DSM-IV catatonic features among psychiatric inpatients. J Nerv Ment Dis. 1996;184:378–379.
   Google Scholar
• Chandrasena R. Catatonic schizophrenia: an international comparative study. Can J Psychiatry. 1986;31:249–252.
   Google Scholar
• Ohaeri JU. Long-term outcome of treated schizophrenia in a Nigerian cohort. Retrospective analysis of 7-year follow-ups. J Nerv Ment Dis. 1993;181: 514–516.
   Google Scholar
• Huang TL, Ree SC, Huang YC, Liu HY, Yang YY. Catatonic features: differential diagnosis and treatments at an emergency unit. Psychiatry Clin Neurosci. 1999;53:63–66.
   Google Scholar
• Benegal V, Hingorani S, Khanna S. Idiopathic catatonia: validity of the concept. Psychopathology. 1993;26:41–46.
   Google Scholar
• Lee JW, Schwartz DL, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry. 2000;12:89–96.
   Google Scholar
• Fisher CM. –Catatonia– due to disulfiram toxicity. Arch Neurol. 1989;46:798–804.
   Google Scholar
• Gingrich JA, Rudnick-Levin F, Almeida C, Innes L, Schneier H. Cocaine and catatonia. Am J Psychiatry. 1998;155:1629.
   Google Scholar
• Lee JW. Catatonic stupor after –ecstasy.– BMJ. 1994;308: 717–718.
   Google Scholar
• Chouinard MJ, Nguyen DK, Clement JF, Bruneau MA. Catatonia induced by levetiracetam. Epilepsy Behav. 2006;8:303–307.
   Google Scholar
• Carroll K GH. Catatonic signs in medical and psychiatric catato-nias. CNS Spectrums. 2000;5:66–69.
   Google Scholar
• Dhossche DM, Carroll BT, Carroll TD. Is there a common neuronal basis for autism and catatonia? Int Rev Neurobiol. 2006;72:151–164.
   Google Scholar
• Cornic f CA, Cohen D. Catatonia in children and adolescents. Psychiatric Annals. 2007;37:19–26.
   Google Scholar
• Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. I. Rating scale and standardized examination. Acta Psychiatr Scand. 1996;93:129–136.
   Google Scholar
• Braunig P, Kruger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry. 1998;39:35–46.
   Google Scholar
• Kruger S BP. Catatonia in affective disorder: new findings and a review of the literature. CNS Spectrums. 2000;5:48–53.
   Google Scholar
• Hare DJ, Malone C. Catatonia and autistic spectrum disorders. Autism. 2004;8:183–195.
   Google Scholar
• Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv. 1998;49:1163–1172.
   Google Scholar
• Starkstein SE, Petracca G, Teson A, Chemerinski E, Merello M, Migliorelli R, Leiguarda R. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry. 1996;60:326–332.
   Google Scholar
• Mimica N, Folnegovic-Smalc V, Folnegovic Z. Catatonic schizophrenia in Croatia. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I17–I20.
   Google Scholar
• Ungvari GS, Chiu HF, Chow LY, Lau BS, Tang WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study. Psychopharmacology (Berl). 1999; 142:393–398.
   Google Scholar
• Clark T, Rickards H. Catatonia. 1: History and clinical features. Hosp Med. 1999;60: 740–742.
   Google Scholar
• Gjessing LR. A review of periodic catatonia. Biol Psychiatry. 1974;8:23–45.
   Google Scholar
• Francis A, Divadeenam KM, Bush G, Petrides G. Consistency of symptoms in recurrent catatonia. Compr Psychiatry. 1997;38: 56–60.
   Google Scholar
• Clark T, Rickards H. Catatonia. 2: Diagnosis, management and prognosis. Hosp Med. 1999;60: 812–814.
   Google Scholar
• Northoff G, Koch A, Wenke J, Eckert J, Boker H, Pflug B, Bogerts B. Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord. 1999;14: 404–416.
   Google Scholar
• Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. J Clin Psychiatry. 1990;51:357–362.
   Google Scholar
• Lohr J, Wisniewski AA. Catatonia. In: Lohr JB, Wisniewski AA (eds) Movement Disorders: A Neuropsychiatric Approach. New York: Guilford Press; 1987.
   Google Scholar
• Bush G, Petrides G, Francis A. Catatonia and other motor syndromes in a chronically hospitalized psychiatric population. Schizophr Res. 1997;27:83–92.
   Google Scholar
• Morrison JR. Catatonia: prediction of outcome. Compr Psychiatry. 1974;15:317–324.
   Google Scholar
• Chalasani P, Healy D, Morriss R. Presentation and frequency of catatonia in new admissions to two acute psychiatric admission units in India and Wales. Psychol Med. 2005;35:1667–1675.
   Google Scholar
• Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I8–I13.
   Google Scholar
• Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12:16–24.
   Google Scholar
• Philbrick KL, Rummans TA. Malignant catatonia. J Neuropsychi-atry Clin Neurosci. 1994;6:1–13.
   Google Scholar
• White DA RA. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry. 1991;158:419–421.
   Google Scholar
• White D. Catatonia and the neuroleptic malignant syndrome–a single entity? Br J Psychiatry. 1992;161:558–560.
   Google Scholar
• Lee JW. Serum iron in catatonia and neuroleptic malignant syndrome. Biol Psychiatry. 1998;44:499–507.
   Google Scholar
• Nisijima K, Kusakabe Y, Ohtuka K, Ishiguro T. Addition of car-bamazepine to long-term treatment with neuroleptics may induce neuroleptic malignant syndrome. Biol Psychiatry. 1998;44:930–931.
   Google Scholar
• Ikebe S, Harada T, Hashimoto T, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Takubo H, Yanagisawa N, Narabayashi H. Prevention and treatment of malignant syndrome in Parkinson–s disease: a consensus statement of the malignant syndrome research group. Parkinsonism Relat Disord. 2003;9 (Suppl 1):S47–S49.
   Google Scholar
• Weller M, Kornhuber J. Amantadine withdrawal and neuroleptic malignant syndrome. Neurology. 1993;43:2155.
   Google Scholar
• Berardi D, Amore M, Keck PE, Jr., Troia M, Dell–Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case-control study. Biol Psychiatry. 1998;44:748–754.
   Google Scholar
• Martin TG. Serotonin syndrome. Ann Emerg Med. 1996;28: 520–526.
   Google Scholar
• Kontaxakis VP, Havaki-Kontaxaki BJ, Christodoulou NG, Paplos KG, Christodoulou GN. Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome? Ann Gen Hosp Psychiatry. 2003;2:10.
   Google Scholar
• Peralta V, Cuesta MJ, Serrano JF, Martinez-Larrea JA. Classification issues in catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251 (Suppl 1):I14–I16.
   Google Scholar
• Rogers D. The motor disorders of severe psychiatric illness: a conflict of paradigms. Br J Psychiatry. 1985;147:221–232.
   Google Scholar
• McKenna PJ, Lund CE, Mortimer AM, Biggins CA. Motor, volitional and behavioural disorders in schizophrenia. 2: The –conflict of paradigms– hypothesis. Br J Psychiatry. 1991;158: 328–336.
   Google Scholar
• Northoff G. What catatonia can tell us about –top-down modulation–: a neuropsychiatric hypothesis. Behav Brain Sci. 2002;25: 555–604.
   Google Scholar
• Northoff G, Eckert J, Fritze J. Glutamatergic dysfunction in cata-tonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neuro-surg Psychiatry. 1997;62:404–406.
   Google Scholar
• Bauer G, Gerstenbrand F, Rumpl E. Varieties of the locked-in syndrome. J Neurol. 1979;221:77–91.
   Google Scholar
• Altshuler LL, Cummings JL, Mills MJ. Mutism: review, differential diagnosis, and report of 22 cases. Am J Psychiatry. 1986;143: 1409–1414.
   Google Scholar
• Levin T, Martin R. Classification of catatonia. Am J Psychiatry. 2004;161:1136.
   Google Scholar
• Swartz C, Francis A, Malur C. Delirium or catatonic disorder due to a general medical condition. J ECT. 2002;18:167–168.
   Google Scholar
• Sadock BJ SV. Comprehensive Textbook of Psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2000.
   Google Scholar
• Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry. 1996;153:231–237.
   Google Scholar
• Moskowitz AK. –Scared stiff–: catatonia as an evolutionary-based fear response. Psychol Rev. 2004;111:984–1002.
   Google Scholar
• Wetzel RD, Reich T, Murphy GE, Province M, Miller JP. The changing relationship between age and suicide rates: cohort effect, period effect or both? Psychiatr Dev. 1987;5:179–218.
   Google Scholar
• Northoff G, Steinke R, Czcervenka C, Krause R, Ulrich S, Danos P, Kropf D, Otto H, Bogerts B. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: investigation of in vivo benzodiazepine receptor binding. J Neu-rol Neurosurg Psychiatry. 1999;67:445–450.
   Google Scholar
• Mastain B, Vaiva G, Guerouaou D, Pommery J, Thomas P. [Favourable effect of zolpidem on catatonia]. Rev Neurol (Paris). 1995;151:52–56.
   Google Scholar
• Thomas P, Rascle C, Mastain B, Maron M, Vaiva G. Test for catatonia with zolpidem. Lancet. 1997;349:702.
   PubMed Web of Science ®Google Scholar
• Seetharam P, Akerman RR. Postoperative echolalia and catatonia responsive to gamma aminobutyric acid receptor agonists in a liver transplant patient. Anesth Annals. 2006;103:785–786.
   Google Scholar
• Hietala J, Syvalahti E, Vuorio K, Rakkolainen V, Bergman J, Haaparanta M, Solin O, Kuoppamaki M, Kirvela O, Ruotsalainen U, Salokangas RKR. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet. 1995;346: 1130–1131.
   Google Scholar
• Northoff G, Steinke R, Nagel DC, Grosser O, Danos P, Genz A, Krause R, Boker H, Otto HJ, Bogerts B. Right lower prefronto-parietal cortical dysfunction in akinetic catatonia: a combined study of neuropsychology and regional cerebral blood flow. Psychol Med. 2000;30:583–596.
   Google Scholar
• Northoff G, Kotter R, Baumgart F, Danos P, Boeker H, Kaulisch T, Schlagenhauf F, Walter H, Heinzel A, Witzel T, Bogerts B. Orbitofrontal cortical dysfunction in akinetic catatonia: a functional magnetic resonance imaging study during negative emotional stimulation. Schizophr Bull. 2004;30:405–427.
   Google Scholar
• Cavada C, Schultz W. The mysterious orbitofrontal cortex. foreword. Cereb Cortex. 2000;10:205.
   PubMed Web of Science ®Google Scholar
• Gehring WJ, Fencsik DE. Functions of the medial frontal cortex in the processing of conflict and errors. J Neurosci. 2001;21: 9430–9437.
   Google Scholar
• Satoh K, Narita M, Someya T, Fukuyama H, Yonekura Y. Functional brain imaging of a catatonic type of schizophrenia: PET and SPECT studies. Jpn J Psychiatry Neurol. 1993;47: 881–885.
   Google Scholar
• Ungvari GS, Leung HC, Lee TS. Benzodiazepines and the psy-chopathology of catatonia. Pharmacopsychiatry. 1994;27: 242–245.
   Google Scholar
• Schmider J, Standhart H, Deuschle M, Drancoli J, Heuser I. A double-blind comparison of lorazepam and oxazepam in psy-chomotor retardation and mutism. Biol Psychiatry. 1999;46: 437–441.
   Google Scholar
• Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137–143.
   Google Scholar
• Gaind GS, Rosebush PI, Mazurek MF. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry. 1994;55:20–23.
   Google Scholar
• Rosebush PI, Mazurek MF. Catatonia: re-awakening to a forgotten disorder. Mov Disord. 1999;14:395–397.
   Google Scholar
• Wells DA. Electroconvulsive treatment for schizophrenia. A ten-year survey in a university hospital psychiatric department. Compr Psychiatry. 1973;14:291–298.
   Google Scholar
• Rohland BM, Carroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29:255–261.
   Google Scholar
• Fricchione G. Catatonia: a new indication for benzodiazepines? Biol Psychiatry. 1989;26:761–765.
   Google Scholar
• Van Den Eede F, Van Hecke J, Van Dalfsen A, Van den Bossche B, Cosyns P, Sabbe BG. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry. 2005;20:422–429.
   Google Scholar
• Petrides G, Divadeenam KM, Bush G, Francis A. Synergism of lorazepam and electroconvulsive therapy in the treatment of cata-tonia. Biol Psychiatry. 1997;42:375–381.
   Google Scholar
• Thomas C, Carroll BT, Maley RT, Jayanti K, Koduri A. Memantine and catatonic schizophrenia. Am J Psychiatry. 2005;162:626.
   PubMedGoogle Scholar
• Carpenter SS, Hatchett AD, Fuller MA. Catatonic schizophrenia and the use of memantine. Ann Pharmacother. 2006;40: 344–346.
   Google Scholar
• Kritzinger PR, Jordaan GP. Catatonia: an open prospective series with carbamazepine. Int J Neuropsychopharmacol. 2001;4: 251–257.
   Google Scholar
• McDaniel WW SD, Sahota AK. Topiramate efect in catatonia: a case series. J Neuropsychiatry Clin Neurosci. 2006;18:234–238.
   Google Scholar
• Zaw ZF, Bates GD. Replication of zolpidem test for catatonia in an adolescent. Lancet. 1997;349:1914.
   Google Scholar
• Cottencin O, Warembourg F, de Chouly de Lenclave MB, Lucas B, Vaiva G, Goudemand M, Thomas P. Catatonia and consultation-liaison psychiatry study of 12 cases. Prog Neuropsychop-harmacol Biol Psychiatry. 2007;31:1170–1176.
   Google Scholar
• Pascual-Leone A, Catala MD, Pascual-Leone Pascual A. Later-alized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on mood. Neurology. 1996;46:499–502.
   Google Scholar
• Klein E, Kreinin I, Chistyakov A, Koren D, Mecz L, Marmur S, Ben-Shachar D, Feinsod M. Therapeutic efficacy of right pre-frontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry. 1999;56:315–320.
   Google Scholar
• Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Char-ney DS. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet. 2000;355:1073–1075.
   Google Scholar
• Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. Catato-nia treated with transcranial magnetic stimulation. Am J Psychiatry. 1998;155:1630.
   Google Scholar
• Saba G, Rocamora JF, Kalalou K, Benadhira R, Plaze M, Aubriot-Delmas B, Januel D. Catatonia and transcranial magnetic stimulation. Am J Psychiatry. 2002;159:1794.
   Google Scholar
• Pommepuy N, Januel D. [Catatonia: resurgence of a concept. A review of the international literature]. Encephale. 2002;28: 481–492.
   Google Scholar
• Fink M, Taylor MA, Ghaziuddin N. Catatonia in autistic spectrum disorders: a medical treatment algorithm. Int Rev Neuro-biol. 2006;72:233–244.
   Google Scholar
• Liddle PF. Commentary on the Modified Rogers Scale and the –conflict of paradigms– hypothesis. Br J Psychiatry. 1991;158: 337–339.
   Google Scholar